Home Data Calendar Blog

ACRS

Tables

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2015-09-30 2014-09-30
Weighted Average Number Of Diluted Shares Outstanding 66.6865.9961.43NA61.2253.9750.34NANANANANANANANANANANANANANANANA
Weighted Average Number Of Shares Outstanding Basic 66.6865.9961.43NA61.2253.9750.34NANANANANANANANANANANANANANANANA
Earnings Per Share Basic -0.30-0.31-0.31-0.37-0.35-0.34-0.57NANANANANANANANANANANANANANANANA
Earnings Per Share Diluted -0.30-0.31-0.31-0.37-0.35-0.34-0.57NANANANANANANANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2015-09-30 2014-09-30
Revenue From Contract With Customer Excluding Assessed Tax 19.021.531.451.501.661.821.781.581.452.051.411.090.985.875.043.671.633.681.121.000.680.000.00
Revenues 19.021.531.451.501.661.821.781.581.452.051.411.090.985.875.043.671.633.681.121.000.680.000.00
Cost Of Revenue 0.921.071.161.151.101.261.201.291.191.391.271.030.830.991.213.511.191.180.970.750.45NANA
Cost Of Goods And Services Sold 0.921.071.161.151.101.261.201.291.191.391.271.030.832.702.783.511.191.180.970.750.45NANA
Costs And Expenses 39.8922.5220.3624.3921.9519.8330.3115.1411.9113.4316.9118.6523.8555.6642.3825.8222.4635.6532.07NANANANA
Research And Development Expense 23.6618.7814.3114.1013.987.907.848.966.876.479.4411.5616.1817.6219.9219.5415.9313.9813.6113.1910.869.412.10
General And Administrative Expense 5.816.086.106.945.985.874.834.903.865.576.206.016.737.998.196.696.578.126.2612.508.121.230.56
Operating Income Loss -20.87-20.99-18.91-22.89-20.30-18.01-28.53-13.56-10.46-11.38-15.51-17.55-22.86-49.79-37.34-39.04-33.45-31.98-30.95-25.44-18.76-10.64-2.66
Allocated Share Based Compensation Expense 4.193.692.353.853.703.832.672.501.943.313.453.194.024.814.864.964.715.255.144.303.670.160.01
Profit Loss -19.95-20.53-18.79-22.80-21.15-18.16-28.75-13.17-10.66-11.60-15.59-18.59-55.32-49.88-37.56-38.55-32.74-31.22-30.23-22.93-18.19NANA
Other Comprehensive Income Loss Net Of Tax -0.14-0.35-0.75-0.220.18-0.04-0.05-0.05-0.06-0.030.11-0.07-0.010.060.020.050.070.14-0.08-0.130.050.00-0.00
Net Income Loss -19.95-20.53-18.79-22.80-21.15-18.16-28.75-13.17-10.66-11.60-15.59-18.59-55.32-49.88-37.56-38.55-32.74-31.22-30.23-22.93-18.19-10.63-2.66
Comprehensive Income Net Of Tax -20.09-20.89-19.54-23.02-20.96-18.20-28.80-13.22-10.72-11.63-15.47-18.66-55.33-49.82-37.55-38.50-32.67-31.08-30.31-23.07-18.14-10.63-2.66

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2015-09-30 2014-09-30
Assets 267.63277.98226.53251.21263.49288.05161.4070.7871.9085.0096.8198.30160.42217.24253.18275.57176.18201.82220.62243.51261.3942.09NA
Liabilities 47.7942.2246.3353.8746.9154.2349.1033.1331.1435.6338.6428.3975.1480.0170.9360.4429.8527.6220.1518.2517.131.90NA
Liabilities And Stockholders Equity 267.63277.98226.53251.21263.49288.05161.4070.7871.9085.0096.8198.30160.42217.24253.18275.57176.18201.82220.62243.51261.3942.09NA
Stockholders Equity 219.84235.75180.20197.34216.58233.81112.2937.6540.7649.3758.1769.9185.28137.23182.25215.12146.33174.20200.47225.26244.26-38.12NA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2015-09-30 2014-09-30
Assets Current 256.57259.35190.88205.03205.78241.26134.5057.4958.0070.9582.7183.80145.37137.89156.81179.50145.52171.17192.26200.22234.1239.36NA
Cash And Cash Equivalents At Carrying Value 61.6568.2636.3427.3553.60113.4535.2722.0623.64NANA34.19NANANANANANA54.8820.2060.0525.4218.89
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 61.6568.2636.3427.3553.60113.4535.2722.0625.4032.5953.9935.9429.9031.6534.2057.0226.5946.0354.8820.2060.05NANA
Accounts Receivable Net Current 0.600.640.630.620.810.940.820.770.890.780.930.700.6719.3715.824.861.032.180.530.48NANANA
Prepaid Expense And Other Assets Current 7.9110.1110.6312.997.098.655.392.591.882.062.783.122.092.823.385.889.173.364.755.885.620.95NA
Available For Sale Securities Debt Securities 186.41187.56167.24198.31190.01152.73107.3932.0729.8335.5325.0139.0861.5383.86102.56110.95107.68118.57132.10188.65NA12.99NA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2015-09-30 2014-09-30
Property Plant And Equipment Gross 5.014.984.824.734.384.334.284.284.864.894.554.545.016.716.105.955.755.352.872.641.530.84NA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 3.873.703.543.393.213.042.852.622.942.662.362.072.152.462.071.671.340.980.680.480.330.08NA
Amortization Of Intangible Assets 0.020.020.02-55.920.020.020.02NANANANANANA1.661.66NANANANANANANANA
Property Plant And Equipment Net 1.151.281.281.331.171.291.421.651.922.232.192.472.854.244.034.284.414.382.192.161.200.76NA
Intangible Assets Net Excluding Goodwill 6.997.017.037.057.077.097.117.127.147.167.187.207.2269.7871.4672.957.297.317.337.35NANANA
Finite Lived Intangible Assets Net 0.360.380.400.420.440.460.480.490.51NANANANANANANANANANANANANANA
Other Assets Noncurrent 2.923.113.383.553.743.914.014.514.844.654.734.834.975.322.380.330.450.460.340.280.200.02NA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2015-09-30 2014-09-30
Liabilities Current 19.7916.2216.7322.9317.8414.9214.5114.8712.7917.7520.6022.4338.9942.7536.2327.3422.2820.0713.8212.769.991.90NA
Accounts Payable Current 7.675.708.129.987.564.247.295.255.085.506.959.9217.7814.1614.5714.7613.7312.508.157.826.480.96NA
Other Accrued Liabilities Current 1.741.921.681.730.611.231.161.170.630.661.231.381.082.342.251.030.670.530.540.470.320.01NA
Accrued Liabilities Current 9.157.575.6910.057.416.933.605.913.829.3410.377.726.0727.6020.7912.598.547.575.674.943.510.94NA
Other Liabilities Current NANA0.720.690.670.650.620.600.590.610.620.640.640.990.870.60NANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2015-09-30 2014-09-30
Deferred Income Tax Liabilities Net 0.370.370.370.370.370.370.370.370.550.550.550.55NANANA0.55NANANANANANANA
Other Liabilities Noncurrent 1.641.842.042.172.512.923.043.183.133.333.483.744.005.123.301.701.771.750.530.560.38NANA
Operating Lease Liability Noncurrent 1.621.822.022.202.382.562.732.893.053.253.403.55NANANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2015-09-30 2014-09-30
Stockholders Equity 219.84235.75180.20197.34216.58233.81112.2937.6540.7649.3758.1769.9185.28137.23182.25215.12146.33174.20200.47225.26244.26-38.12NA
Additional Paid In Capital 875.98871.80795.37792.97789.19785.46645.73542.29532.17530.06527.24523.50520.21516.84512.04507.37400.07395.27390.46384.94380.87NANA
Retained Earnings Accumulated Deficit -654.68-634.73-614.20-595.41-572.60-551.46-533.30-504.54-491.37-480.71-469.11-453.53-434.93-379.61-329.74-292.17-253.62-220.88-189.66-159.44-136.50-38.12NA
Accumulated Other Comprehensive Income Loss Net Of Tax -1.47-1.33-0.97-0.22-0.00-0.18-0.14-0.09-0.040.010.05-0.07-0.000.01-0.05-0.07-0.12-0.19-0.33-0.25-0.110.00NA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 4.193.692.35NA3.703.832.67NA1.943.313.45NA3.324.814.864.964.715.255.144.303.67NANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2015-09-30 2014-09-30
Net Cash Provided By Used In Operating Activities -7.82-19.67-20.97-17.07-10.61-12.22-12.23-8.86-12.15-10.82-6.80-20.39-23.36-21.38-31.32-27.25-29.86-21.83-21.87-18.21-13.71NANA
Net Cash Provided By Used In Investing Activities 1.22-21.2229.93-9.18-37.67-45.47-75.31-2.315.24-10.4913.9456.4421.6718.958.62-70.5110.3913.2956.19-21.57-39.86NANA
Net Cash Provided By Used In Financing Activities -0.0172.810.03-0.00-11.57135.87100.757.83-0.28-0.1010.92-30.01-0.07-0.12-0.12128.180.02-0.300.36-0.0880.92NANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2015-09-30 2014-09-30
Net Cash Provided By Used In Operating Activities -7.82-19.67-20.97-17.07-10.61-12.22-12.23-8.86-12.15-10.82-6.80-20.39-23.36-21.38-31.32-27.25-29.86-21.83-21.87-18.21-13.71NANA
Net Income Loss -19.95-20.53-18.79-22.80-21.15-18.16-28.75-13.17-10.66-11.60-15.59-18.59-55.32-49.88-37.56-38.55-32.74-31.22-30.23-22.93-18.19-10.63-2.66
Profit Loss -19.95-20.53-18.79-22.80-21.15-18.16-28.75-13.17-10.66-11.60-15.59-18.59-55.32-49.88-37.56-38.55-32.74-31.22-30.23-22.93-18.19NANA
Depreciation Depletion And Amortization 0.190.210.210.200.190.250.29-0.450.590.610.580.321.632.232.230.960.380.320.220.180.12NANA
Increase Decrease In Accounts Receivable -0.040.000.01-0.19-0.130.120.04-0.120.11-0.16-4.74-12.19-1.513.5510.963.83-1.15NANANANANANA
Increase Decrease In Accounts Payable 1.96-2.42-1.862.362.58-3.131.840.230.58-1.71-4.32-6.213.63-0.39-0.201.031.244.380.321.43-0.03-0.04NA
Share Based Compensation 4.193.692.353.853.703.832.672.501.943.313.453.183.324.814.864.964.715.255.144.303.670.16NA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2015-09-30 2014-09-30
Net Cash Provided By Used In Investing Activities 1.22-21.2229.93-9.18-37.67-45.47-75.31-2.315.24-10.4913.9456.4421.6718.958.62-70.5110.3913.2956.19-21.57-39.86NANA
Payments To Acquire Property Plant And Equipment 0.150.190.160.200.06NANA0.010.300.020.120.270.820.240.280.150.560.350.300.580.270.13NA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2015-09-30 2014-09-30
Net Cash Provided By Used In Financing Activities -0.0172.810.03-0.00-11.57135.87100.757.83-0.28-0.1010.92-30.01-0.07-0.12-0.12128.180.02-0.300.36-0.0880.92NANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2015-09-30 2014-09-30
Revenues 19.021.531.451.501.661.821.781.581.452.051.411.090.985.875.043.671.633.681.121.000.680.000.00
Revenue From Contract With Customer Excluding Assessed Tax 19.021.531.451.501.661.821.781.581.452.051.411.090.985.875.043.671.633.681.121.000.680.000.00
Corporate Non -3.21-3.18-2.87-2.16-1.92-1.88-1.67-1.83-1.68-1.80-2.22-3.79-1.96-2.92-3.93-3.08-2.11-1.91-1.38-0.99-0.53NANA
Intersegment Elimination, Contract Research 3.203.202.902.101.901.901.7013.201.701.80-2.22-125987.29-1.96-2.92-3.93-3.08-2.11-1.91-1.38-0.99-0.53NANA
Laboratory Research Revenue 1.091.221.221.271.421.611.531.411.331.851.191.090.980.891.261.271.121.141.121.000.68NANA
Other Revenue 0.030.310.230.230.240.220.240.170.120.190.22NANANANA0.500.001.00NANANANANA
License And Service 17.90NANANA0.21NANANANANANANANANANANANANANANANANANA
Royalty, Asset Purchase Agreement Encompassing Worldwide Rights To Oxymetazoline Hydrochloride Cream Plus Intellectual Property 0.300.30NANA0.200.20NANANANANANANANANANANANANANANANANA
Contract Research 4.304.404.103.433.333.483.203.243.023.663.414.882.943.815.194.363.233.052.501.991.21NANA
Dermatology Therapeutics 17.930.310.230.230.240.220.240.170.120.190.22NANA4.983.782.400.512.53NANANANANA

Plots across concepts


IncomeStatement
Operating Income Loss
Expenses
Other Nonoperating Income Expense
Balance Sheet
Operating Lease Liability
Assets
Property Plant And Equipment Net
Current Assets
Accounts Receivable Net Current
NonCurrent Assets
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
Property Plant And Equipment Net
Liabilities
Operating Lease Liability
Current Liabilities
Other Liabilities Current
Noncurrent Liabilities
Deferred Income Tax Liabilities Net
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Income Loss
NetCashProvidedByUsedInOperatingActivities
Net Income Loss
NetCashProvidedByUsedInInvestingActivities
Payments To Acquire Property Plant And Equipment
Shares
Weighted Average Number Of Diluted Shares Outstanding
OperatingLeaseLiability
Operating Lease Liability Current
FiniteLivedIntangibleAssets
Finite Lived Intangible Assets Net

Line plots across dimensions of each concept


TTM Greenblatt ROC
_
(None,)
T T M  Greenblatt  R O C_
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:StatementBusinessSegments
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Statement Business Segments
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service
us-gaap:OperatingIncomeLoss
us-gaap:StatementBusinessSegments
(None,)
Operating Income Lossus-gaap: Statement Business Segments
us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:IncomeStatementLocation
(None,)
Allocated Share Based Compensation Expenseus-gaap: Income Statement Location
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FinancialInstrument
(None,)
Available For Sale Securities Debt Securitiesus-gaap: Financial Instrument
us-gaap:PropertyPlantAndEquipmentGross
us-gaap:PropertyPlantAndEquipmentByType
(None,)
Property Plant And Equipment Grossus-gaap: Property Plant And Equipment By Type
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:StatementBusinessSegments
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Statement Business Segments
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service